Authors

The Economic Rationale for Adherence in the Treatment of Type 2 Diabetes Mellitus

Shifting Cardiovascular Care to Nurses Results in Structured Chronic Care

This study sought to explore if shifting care to nurses in cardiovascular risk management in primary care is a key to more structured chronic care.

Economic Considerations for the Treatment of Opioid and Alcohol Dependence: A Managed Care Perspective

Pediatric Integrated Delivery System's Experience With Pandemic Influenza A (H1N1)

Experience of a pediatric integrated delivery system with the surge from the 2009 H1N1 pandemic is described, emphasizing scale, scope, and flexibility at multiple locations.

Intensive Care Management of a Complex Medicaid Population: A Randomized Evaluation

The authors present findings of a randomized evaluation of Medicaid patients at an academic medical center, which found that intensive care management was associated with reduced total medical expense.

Strategies for Identifying and Channeling Patients for Depression Care Management

This article examines screening strategies for possible depression in the context of a care management program for chronically ill Medicare recipients.

Medical Utilization Surrounding Initial Opioid-Related Diagnoses by Coding Method

Medical utilization profiles of commercially insured members with opioid-related disorders differ depending on the code used to document the initial diagnosis in administrative claims.

Treatment Modification After Initiating Second-Line Medication for Type 2 Diabetes

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.

The Need to Level the Playing Field Between Accountable Care Organizations and Medicare Advantage

For several reasons, including meeting the HHS Secretary’s Medicare quality and value payment goals, the ACO program needs to reformed to equate with Medicare Advantage.

The Importance of Appropriate Treatment of Chronic Bronchitis

Reporting Provider Performance: What Can Be Learned From the Experience of Multi-Stakeholder Community Coalitions?

Pragmatic Clinical Trials: US Payers' Views on Their Value

Payers like key traits of pragmatic clinical trials, but are wary of pharmaceutical companies and plan to carefully scrutinize this new, appealing type of evidence.

Contributor: Prioritizing Patient-Centered Value Over International Reference Pricing in US Drug Policy

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone.

Cost of Post-Traumatic Stress Disorder vs Major Depressive Disorder Among Patients Covered by Medicaid or Private Insurance

Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion

Follow-Up Among Women with an Abnormal Mammogram in an HMO: Is It Timely, Complete, and Efficient?

Severity of Hereditary Angioedema, Prevalence, and Diagnostic Considerations

Preventive/Office Visit Patient Knowledge and Their Insurance Information Gathering Perceptions

Patients have an incomplete understanding of what constitutes no-cost preventive care services. Ease of obtaining information from insurance companies can significantly affect whether patients are charged correctly.

Patient Safety-Focused Medication Therapy Management: Challenges Affecting Future Implementation

Lessons learned from implementation of a pharmacist-delivered medication therapy management intervention in primary care can inform future studies and be adopted into real-world clinical settings.

Efficient Evaluation of Thyroid Nodules by Primary Care Providers and Thyroid Specialists

Factors Affecting Patient Compliance With Antihyperlipidemic Medications in an HMO Population

Advancing Health Equity Through Medication Formulary Policy

Medication formulary policies represent a key determinant of access to medication and can be leveraged to advance pharmacoequity and health equity writ large.

US Prevalence of Upper Gastrointestinal Symptoms: A Systematic Literature Review

Systematic review and meta-analysis suggest that upper gastrointestinal symptoms and disorders are common to inhabitants of the United States.

A Physician-led Accountable Care Organization: From Award to Implementation

Gaps in ACO implementation readiness are identified as appointment reminders, referral follow-ups, care management, care transition alerts, clinical quality measure knowledge, and resources.

Bridging the Electronic Divide: Patient and Provider Perspectives on E-mail Communication in Primary Care

Factors Associated with Healthcare Costs in Women with Fibromyalgia

Unmet Medical Needs and Other Challenges in the Treatment of Patients With Schizophrenia

Measuring Overuse With Electronic Health Records Data

Electronic health records data can accurately quantify overuse of clinical services and the risk factors that may trigger low-value testing and screening.

Impact of Clinical Pharmacy Services on Outcomes and Costs for Indigent Patients With Diabetes

Clinical pharmacy specialists impact patient care through improvements in clinical outcomes for diabetes, hypertension, and dyslipidemia via clinical interventions and promotion of medication adherence.